Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous magnesium sulfate for pain during transradial coronary angiography
IRCT20241113063693N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in procedural pain comparing Magnesium sulfate with Placebo control (2 arms). Primary endpoints: Pain severity, Amount of need for opioid analgesics and 3 more. Started Dec 2024; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
procedural pain
Beyond the preview
Go deeper on IRCT20241113063693N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241113063693N1.